• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

    6/12/24 7:00:00 AM ET
    $ASPI
    $ATRA
    $CIA
    $CLNN
    Major Chemicals
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ASPI alert in real time by email

    MIAMI, June 12, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 72nd Emerging Growth Conference on June 12 & 13, 2024.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    Questions@EmergingGrowth.com

    For updates, follow us on Twitter

    Sponsors:

    QuoteMedia - Keep Investors Informed with Dynamic Plug and Play IR Solutions

    (844) 485-8200

    Sales@QuoteMedia.com

    www.QuoteMedia.com

    ProCore Advisory - Unleashing the power of strategic investor relations for public and pre-IPO companies

    (832)-847-1327

    pierre@procoreadvisory.com

    www.procoreadvisory.com

    Day 2

    June 13, 2024

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 - 9:35

    FBR, Ltd. (OTCQB:FBRKF) (ASX: FBR) 

    Keynote speaker: Michael John Pivac, CEO & Managing Director

    9:40 - 10:10

    Huize Holding Limited (NASDQQ: HUIZ)

    Keynote speaker: Mr. Ron Tam, Co CFO

    10:15 - 10:45

    Ascend Wellness Holdings Inc. (OTCQX:AAWH)

    Keynote speaker: Rebecca Koar, EVP of Investor Relations and Strategy

    10:50 – 11:20

    Targa Exploration Corp. (OTCQB:TRGEF) (CSE:TEX)

    Keynote speaker: Cameron Tymstra, President & CEO

      

    11:25 - 11:55

    Sucro Limited (TSXV:SUG) (OTCQB:SUGCF)

    Keynote speaker: Don Hill, Chairman

    12:00 – 12:30

    Patriot AG Corp.

    Keynote speaker: Eric Till, CEO / CFO, & Kyle Severson, COO

    12:35 – 1:05

    Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

    Keynote speaker: Jason Awe, Head of Corporate Communications & IR

    1:10 – 1:40

    Bioxytran, Inc. (OTCQB:BIXT)

    Keynote speakers: David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

      

    1:45 - 2:15

    InMed Pharmaceuticals, Inc. (NASDAQ:INM)

    Keynote speaker: Eric Adams, CEO

    2:20 – 2:30

    Immuron Limited (NASDAQ:IMRN)

    Keynote speaker: Steve Lydeamore, CEO

    2:35 - 2:45

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Gerald W. Shields, Vice Chairman and CEO Jeff Conklin, CFO

    2:50 – 3:00

    Digital Brand Media & Marketing Group, Inc. (OTC:DBMM)

    Keynote speaker: Reggie James, COO, Sr. VP & Exec. Director

    3:05 – 3:15

    ATRenew Inc. (NYSE:RERE)

    Keynote speakers: Jessie Jin, Investor Relations Manager & Jeremy Ji, Director of Corporate Development & Investor Relations

    3:20 - 3:30

    Meihua International Medical Technologies Co. (NASDAQ:MHUA)

    Keynote speaker: Mr. Steven Wang, CEO

    3:35 – 3:45

    GTI Energy, Ltd. (OTC:GTRIF) (ASX: GTR)

    Keynote speaker: Bruce Lane, Executive Director, CEO

    Presenting Today, June 12, 2024

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Perfect Corp. (NYSE:PERF)

    Keynote speaker: Louis Chen, EVP, CSO

    9:40 - 10:10

    Intellabridge Technology Corporation (OTCQB:KASHF) (CSE:KASH)

    Keynote speaker: John Eagleton, CEO

    10:15 - 10:45

    Pulsar Helium, Inc.'s (OTCQB:PSRHF) (TSXV:PLSR)

    Keynote speaker: Thomas Abraham-James President / CEO

    10:50 - 11:20

    Cadrenal Therapeutics, Inc. (NASDAQ:CVKD)

    Keynote speaker: Mr. Quang X. Pham, Chairman & CEO

    11:25 - 11:55

    LogicMark, Inc. (NASDAQ:LGMK)

    Keynote speaker: Ms. Chia-Lin Simmons, CEO

      

    12:00 - 12:30

    Unusual Machines, Inc. (NYSE:UMAC)

    Keynote speaker: Allan Evans, CEO

    12:35 - 1:05

    SeaStar Medical Holding Corporation (NASDAQ:ICU)

    Keynote speaker: Eric Schlorff, President / CEO, Director

    1:10 - 1:40

    Diakonos Oncology, Inc.

    Keynote speakers: Jay Hartenbach, COO, & Anthony Baldor, CFO & Head of Business Development

    1:45 - 2:15

    Longeveron, Inc. (NASDAQ:LGVN)

    Keynote speaker: Mohamed Wa'el Hashad, CEO & Director

    2:20 - 3:00

    Clene Inc., (NASDAQ:CLNN)

    Keynote speaker: Rob Etherington, President / CEO, & Morgan Grown, CFO

    Postponed to July

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, and Harry M. Lander, Ph.D. Senior Scientific Consultant

    3:20 - 3:30

    SenesTech, Inc. (NASDAQ:SNES)

    Keynote speaker: Joel L. Fruendt, President, CEO, & Director

    3:35 - 4:05

    ASP Isotopes Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    Questions@EmergingGrowth.com

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: Conference@EmergingGrowth.com



    Primary Logo

    Get the next $ASPI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASPI
    $ATRA
    $CIA
    $CLNN

    CompanyDatePrice TargetRatingAnalyst
    Unusual Machines Inc.
    $UMAC
    5/15/2026$20.00 → $22.00Buy
    Needham
    Unusual Machines Inc.
    $UMAC
    5/13/2026$25.00Buy
    Roth Capital
    Atara Biotherapeutics Inc.
    $ATRA
    5/8/2026$13.00Hold → Buy
    Canaccord Genuity
    Atara Biotherapeutics Inc.
    $ATRA
    1/13/2026$6.00Buy → Hold
    Canaccord Genuity
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Unusual Machines Inc.
    $UMAC
    8/19/2025$15.00Buy
    Needham
    Unusual Machines Inc.
    $UMAC
    12/18/2024$18.00Buy
    Maxim Group
    Longeveron Inc.
    $LGVN
    12/6/2024$10.00Buy
    ROTH MKM
    More analyst ratings

    $ASPI
    $ATRA
    $CIA
    $CLNN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Stenberg Jon bought $48,192 worth of Citizens (10,000 units at $4.82), increasing direct ownership by 3% to 327,574 units (SEC Form 4)

    4 - CITIZENS, INC. (0000024090) (Issuer)

    5/26/26 10:28:12 AM ET
    $CIA
    Life Insurance
    Finance

    Large owner Adar1 Capital Management, Llc bought $721,548 worth of shares (468,551 units at $1.54) (SEC Form 4)

    4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)

    5/21/26 5:08:05 PM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Glenbrook Capital Management bought $53,486 worth of shares (32,120 units at $1.67) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    5/18/26 8:11:14 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ASPI
    $ATRA
    $CIA
    $CLNN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements

    Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ:INM) ("InMed" or the "Company"), today announce that it had received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on June 3, 2026 informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement for continued listing on Nasdaq.As previously disclosed, the Company was notified by Nasdaq on March 27, 2026 that its common shares had failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. Nasdaq has now determined that the closing bid price of the Com

    6/4/26 5:00:00 PM ET
    $INM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Longeveron to Present at BIO International Convention 2026

    Company will highlight new and recently published data for stem cell therapy laromsestrocel Focus on potential partnership and strategic opportunities for Hypoplastic Left Heart Syndrome, Alzheimer's disease, Pediatric Dilated Cardiomyopathy and Aging-related FrailtyCorporate presentation Wednesday, June 24th at 2:15pm PT in Theater 4 MIAMI, June 04, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company will participate in the BIO International Convention taking place June 22-25, 2026 at the San Diego Convention Ce

    6/4/26 9:15:00 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    America's Caregiving Dilemma: 90% Burnout, a Gen Z Reckoning, and the AI Lifeline Families Need

    LOUISVILLE, Ky., June 04, 2026 (GLOBE NEWSWIRE) -- A comprehensive new national survey commissioned by LogicMark, Inc. (OTC:LGMK), a provider of personal safety and connected care technology, reveals the full scope of America's caregiving crisis: 90% of current family caregivers show symptoms of burnout, and the youngest generation is bearing a disproportionate share of the burden. At the same time, nearly 8 in 10 caregivers say they would embrace AI-powered health monitoring, contradicting the assumption that technology is unwelcome in caregiving. These findings emerge at a moment of national urgency, with 63 million Americans now serving as family caregivers, nearly 1 in 4 adults. The e

    6/4/26 9:00:00 AM ET
    $LGMK
    Industrial Specialties
    Health Care

    $ASPI
    $ATRA
    $CIA
    $CLNN
    SEC Filings

    View All

    SEC Form S-8 filed by Clene Inc.

    S-8 - Clene Inc. (0001822791) (Filer)

    6/5/26 4:09:36 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Longeveron Inc. filed SEC Form 8-K: Leadership Update

    8-K - Longeveron Inc. (0001721484) (Filer)

    6/5/26 4:01:14 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Unusual Machines Inc.

    144 - Unusual Machines, Inc. (0001956955) (Subject)

    6/5/26 10:14:35 AM ET
    $UMAC
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ASPI
    $ATRA
    $CIA
    $CLNN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham reiterated coverage on Unusual Machines with a new price target

    Needham reiterated coverage of Unusual Machines with a rating of Buy and set a new price target of $22.00 from $20.00 previously

    5/15/26 7:50:30 AM ET
    $UMAC
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Roth Capital initiated coverage on Unusual Machines with a new price target

    Roth Capital initiated coverage of Unusual Machines with a rating of Buy and set a new price target of $25.00

    5/13/26 8:09:23 AM ET
    $UMAC
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Atara Biotherapeutics upgraded by Canaccord Genuity with a new price target

    Canaccord Genuity upgraded Atara Biotherapeutics from Hold to Buy and set a new price target of $13.00

    5/8/26 8:40:39 AM ET
    $ATRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ASPI
    $ATRA
    $CIA
    $CLNN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and Chairman Pham Quang X sold $36,209 worth of shares (8,285 units at $4.37) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 173,224 units (SEC Form 4)

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    6/5/26 5:26:24 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President Camden Andrew Ross sold $3,004,790 worth of shares (100,000 units at $30.05), decreasing direct ownership by 29% to 246,750 units (SEC Form 4)

    4 - Unusual Machines, Inc. (0001956955) (Issuer)

    6/5/26 4:10:05 PM ET
    $UMAC
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Director Davis Jerry increased direct ownership by 2% to 74,985 units (SEC Form 4)

    4 - CITIZENS, INC. (0000024090) (Issuer)

    6/4/26 5:06:50 PM ET
    $CIA
    Life Insurance
    Finance

    $ASPI
    $ATRA
    $CIA
    $CLNN
    Leadership Updates

    Live Leadership Updates

    View All

    Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities

    MIAMI, May 20, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company's Chief Executive Officer, Stephen Willard, issued the following letter to Longeveron stockholders. Dear Fellow Stockholders, I am delighted to join Longeveron at what I believe is an extraordinary time for the Company and our stem cell therapy, laromestrocel (Lomecel-B®). Longeveron is progressing through a significant inflection point in the Company's history. After taking on the CEO role in February, we embarked on two immediate critical task

    5/20/26 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    It's in the Code—the Future of Autonomous Warfare

    AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: The nature of modern conflict is being fundamentally rewritten, driven by the explosive proliferation of cheap, mass-produced drones that are upending the economics of warfare. In war-torn settings such as Ukraine, millions of low-cost systems, often assembled in small workshops or adapted from off-the-shelf commercial hardware, are now performing functions once only sophisticated aircraft and expensive precision munitions could do. However, while drone hardware has grown abundant and affordable, a glaring constraint has surfaced: The vast majority of these systems lack the intelligence needed to operate indepen

    5/13/26 8:30:00 AM ET
    $DPRO
    $RCAT
    $SWMR
    Aerospace
    Industrials
    Computer Software: Prepackaged Software
    Technology

    The Real Drone Revolution Is Happening Inside the Code

    AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: The nature of modern warfare is being rewritten in real time, driven by the rapid rise of cheap, mass-produced drones that are reshaping the economics of conflict. In war zones such as Ukraine, millions of low-cost systems, often built in small workshops or adapted from commercial designs, are now performing missions once reserved for advanced aircraft and precision-guided weapons. But while the hardware has become abundant and accessible, a critical limitation has emerged: Most of these drones lack the intelligence to operate independently in contested environments. GPS jamming, electronic warfare and the need

    5/11/26 8:30:00 AM ET
    $DPRO
    $RCAT
    $SWMR
    Aerospace
    Industrials
    Computer Software: Prepackaged Software
    Technology

    $ASPI
    $ATRA
    $CIA
    $CLNN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

    SC 13D/A - LogicMark, Inc. (0001566826) (Subject)

    12/3/24 3:35:39 PM ET
    $LGMK
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $ASPI
    $ATRA
    $CIA
    $CLNN
    Financials

    Live finance-specific insights

    View All

    ATRenew Inc. Reports Unaudited First Quarter 2026 Financial Results

    SHANGHAI, May 19, 2026 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE:RERE), a pioneer in technology-driven recycling and trade-in solutions for consumer products in China, today announced its unaudited financial results for the three months ended March 31, 2026. First Quarter 2026 HighlightsTotal net revenues grew by 32.4% to RMB6,160.1 million (US$893.0 million) from RMB4,653.5 million in the same period of 2025.Income from operations increased by 154.9% to RMB185.3 million (US$26.9 million) from RMB72.7 million in the same period of 2025. Adjusted income from operations (non-GAAP)[1] grew by 70.2% to RMB190.5 million (US$27.6 million) from RMB111.9 million in the same per

    5/19/26 4:00:00 AM ET
    $RERE
    Other Specialty Stores
    Consumer Discretionary

    LogicMark, Inc. Announces Strong First Quarter 2026 Results

    LOUISVILLE, Ky., May 13, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC:LGMK) (the "Company"), a provider of personal safety and emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced financial and operational results for the first quarter ended March 31, 2026. Financial Highlights First quarter 2026 revenue increased 24% to $3.2 million compared to the same period last year. Revenue has increased year-over-year in seven of the last eight quarters.Gross margin expanded 610 basis points to 69.6%, up from 63.5% in the prior-year period.Total operating expenses declined 7% to $3.7 million, compared with $4.0 m

    5/13/26 4:05:00 PM ET
    $LGMK
    Industrial Specialties
    Health Care

    Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update

    On track for August 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for hypoplastic left heart syndrome, a rare pediatric disease and orphan-designated indicationClosed a private placement of up to $30 million, with $15 million funded in the initial closing, led by Coastlands Capital with participation from Janus Henderson Investors and other healthcare focused fundsCompany to host conference call and webcast today at 4:30 p.m. ET MIAMI, May 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic agi

    5/13/26 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care